ESRP1 has been reported as controlling ER+ breast cancer [60], and ESRP1/ESRP2 were noted as being the most strongly down-regulated RBPs in epithelial-to-mesenchymal transition (EMT) in a cell culture model of breast cancer [61]. Here, ESRP1 is linked to breast cancer.